Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

Documenti analoghi

• Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model
  di: Wagenaar, Laura, et al.
  Pubblicazione: (2018)
• Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
  di: Marlotte M. Vonk, et al.
  Pubblicazione: (2017-09-01)
• The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
  di: Vonk, Marlotte M., et al.
  Pubblicazione: (2017)
• Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
  di: Vonk, Marlotte M., et al.
  Pubblicazione: (2017)
• A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
  di: Smit, J, et al.
  Pubblicazione: (2013)